Slowing the ACO1 vitality decreased the capability of T-cell lymphoblastic neoplasia cells, and ACO1 knockdown makes resistant cell lines susceptible to fluorocitrate, which represented that ACO1 is a new powerful therapeutic strategy for the healing of diverse cancers (22). This evidence concerns the gene ACO1 and cancer.